Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $1.43 Million - $1.67 Million
14,855 Added 18.79%
93,928 $9.66 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $7.28 Million - $7.7 Million
67,853 Added 604.75%
79,073 $8.63 Million
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $12.3 Million - $22.4 Million
-196,584 Reduced 94.6%
11,220 $1.28 Million
Q3 2022

Nov 14, 2022

SELL
$58.92 - $84.67 $1.55 Million - $2.23 Million
-26,359 Reduced 11.26%
207,804 $12.9 Million
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $6.3 Million - $9.23 Million
79,349 Added 51.25%
234,163 $18.7 Million
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $6.57 Million - $8.35 Million
-76,069 Reduced 32.95%
154,814 $16.3 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $22.8 Million - $27.7 Million
230,883 New
230,883 $24.9 Million
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $7.33 Million - $8.8 Million
-79,776 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$86.24 - $95.92 $1.06 Million - $1.18 Million
-12,282 Reduced 13.34%
79,776 $7.47 Million
Q1 2021

May 17, 2021

BUY
$71.83 - $95.48 $6.35 Million - $8.44 Million
88,364 Added 2392.1%
92,058 $8.47 Million
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $6.8 Million - $8.56 Million
-101,493 Reduced 96.49%
3,694 $270,000
Q3 2020

Nov 16, 2020

BUY
$55.23 - $79.93 $5.81 Million - $8.41 Million
105,187 New
105,187 $8.17 Million
Q1 2020

May 15, 2020

SELL
$24.87 - $38.56 $1.97 Million - $3.06 Million
-79,311 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$25.43 - $36.67 $4.48 Million - $6.46 Million
-176,080 Reduced 68.95%
79,311 $2.87 Million
Q3 2019

Nov 14, 2019

SELL
$23.0 - $27.97 $6.33 Million - $7.7 Million
-275,257 Reduced 51.87%
255,391 $6.95 Million
Q2 2019

Aug 14, 2019

BUY
$22.81 - $28.48 $12.1 Million - $15.1 Million
530,648 New
530,648 $12.8 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.